LEUKOCERT Trademark

Trademark Overview


On Thursday, September 19, 2024, a trademark application was filed for LEUKOCERT with the United States Patent and Trademark Office. The USPTO has given the LEUKOCERT trademark a serial number of 98759613. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 19, 2024. This trademark is owned by Sanguine Biosciences, Inc.. The LEUKOCERT trademark is filed in the Transportation & Storage Services, Computer & Software Services & Scientific Services, and Chemical Products categories with the following description:

Distribution services, namely, delivery of cells, sub-cellular fractions, antibodies, reagents, culture media, and biological tissue, namely, immune cells, bone marrow, and pooled serum from either plasma or whole blood

Cells, sub-cellular fractions, antibodies, reagents and culture media for scientific, laboratory, and research use; Immune cells isolated from leukapheresis collections by immunomagnetic or density gradient separation from normal, healthy human donors for scientific, laboratory, and research use; Human AB serum derived from either plasma or whole blood from normal, healthy male human donors with AB blood type for scientific, laboratory, research, and further manufacturing use

Manufacturing and processing of cells in the field of cell therapies for medical and scientific research; Bone marrow aspiration for medical and scientific research; Research and development services in the field of cell therapies; Custom production and manufacture of advanced therapeutics such as cell and gene therapies for others for medical and scientific research; Leukapheresis collections from normal, healthy human donors for use as a source material for manufacturing and processing of cells for laboratory, medical and scientific research; Cell therapy services, namely, manufacturing and processing of Human AB serum and leukapheresis material for human biotherapies and in vivo therapies for laboratory, medical and scientific research; Medical services for cell sampling and isolation, namely, leukapheresis medical treatment services for laboratory, medical and scientific research
leukocert

General Information


Serial Number98759613
Word MarkLEUKOCERT
Filing DateThursday, September 19, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDistribution services, namely, delivery of cells, sub-cellular fractions, antibodies, reagents, culture media, and biological tissue, namely, immune cells, bone marrow, and pooled serum from either plasma or whole blood
Goods and ServicesCells, sub-cellular fractions, antibodies, reagents and culture media for scientific, laboratory, and research use; Immune cells isolated from leukapheresis collections by immunomagnetic or density gradient separation from normal, healthy human donors for scientific, laboratory, and research use; Human AB serum derived from either plasma or whole blood from normal, healthy male human donors with AB blood type for scientific, laboratory, research, and further manufacturing use
Goods and ServicesManufacturing and processing of cells in the field of cell therapies for medical and scientific research; Bone marrow aspiration for medical and scientific research; Research and development services in the field of cell therapies; Custom production and manufacture of advanced therapeutics such as cell and gene therapies for others for medical and scientific research; Leukapheresis collections from normal, healthy human donors for use as a source material for manufacturing and processing of cells for laboratory, medical and scientific research; Cell therapy services, namely, manufacturing and processing of Human AB serum and leukapheresis material for human biotherapies and in vivo therapies for laboratory, medical and scientific research; Medical services for cell sampling and isolation, namely, leukapheresis medical treatment services for laboratory, medical and scientific research

Classification Information


International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateThursday, September 19, 2024
Primary Code039
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 19, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, September 19, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanguine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Trademark Events


Event DateEvent Description
Thursday, September 19, 2024NEW APPLICATION ENTERED